The tragedy that is today’s opioid epidemic has prompted robust federal and state legislative and regulatory interventions in both the legal and illicit opioid markets—albeit with mixed success. As these initiatives have been slow to quell the opioid crisis, public nuisance claims have taken center stage.
LINKS
Click here to read "Prescription for Failure: Public Nuisance Claims Against the Opioid Industry" co-authored by Francis A. Citera for the University of Miami Law Review.